More PRNewswire
View Older Stories View Newer Stories-
Valens Semiconductor Acquires Acroname, Bolstering its Innovative USB Offering for the Industrial Market
-
HistoIndex to Showcase Groundbreaking AI-powered Stain-free Digital Pathology Advances with 8 Accepted Abstracts at EASL Congress 2024
-
Syndigo Study: Incomplete, Inconsistent Product Content Impacts Retailers' Sales
-
Amwins Partners with Kilpatrick Companies
-
Trulieve Announces Opening of 200th Dispensary
-
Over 1,000 Sign-On to Oppose House Plan to Exclude CBOs from PreK for All
-
WildFire Energy Announces Bolt-On Eagle Ford Acquisition
-
Elastin Biosciences Announces Positive Preclinical In Vivo Data Demonstrating Elastin Preservation and Restoration in Models of Abdominal Aortic Aneurysm and Williams Syndrome
-
Thompson Thrift Earns Spot on IBJ Fast 25 List of Fastest-Growing Companies
-
Ledge Launches First-of-its-Kind PartyPad™
-
LANDSEA HOMES CLOSES ON 44 HOMESITES FOR A NEW COMMUNITY IN ANAHEIM, CA
-
Matterworks Launches PyxisTM - First AI-Powered, Turn-Key Platform for Identification and Absolute Quantitation from Mass Spectrometry Data
-
Caixin Summer Summit 2024 Concludes Successfully: Embracing 'New Missions, New Responsibilities'
-
Omdia research predicts DCIM market to reach $6.3bn by 2030, accelerating OT-IT convergence
-
TDS TO SELL ITS ONENECK BUSINESS TO US SIGNAL
-
30TH EDITION OF THE CONFERENCE OF MONTREAL: A MILESTONE IN GLOBAL COLLABORATION
-
Beyond Borders 2024: Innovative biotech industry is well positioned for a comeback when the financing environment improves, says EY report:
-
Paul Thompson is new CEO of KinderCare Learning Companies
-
Kenon Holdings Reports Q1 2024 Results and Additional Updates
-
Welltower Raises 2024 Guidance and Issues Business Update
-
Welltower Board of Directors Approves 10% Increase in Quarterly Dividend to 67c per Share
-
USANA Executive Chairman Kevin Guest Encourages Self-Renewal with June's "Rebuild Your Life Month"
-
Neurocrine Biosciences Announces Publication of Primary CAHtalyst™ Pediatric Phase 3 Study Results of Crinecerfont for the Treatment of CAH in The New England Journal of Medicine
-
Relmada Therapeutics to Participate in the 2024 Jefferies Global Healthcare Conference
-
Neurocrine Biosciences Announces Publication of Primary CAHtalyst™ Adult Phase 3 Study Results of Crinecerfont for the Treatment of CAH in The New England Journal of Medicine
-
AUXLY ANNOUNCES ANNUAL GENERAL MEETING OF SHAREHOLDERS
-
Health Recovery Solutions Appoints Jason Comer as CEO to Lead Next Phase of Growth
-
DeFi Technologies' New Business Line, DeFi Alpha, a Specialized Arbitrage Trading Desk, Generates an Additional C$59.2 Million (US$43.4 Million) from Low-Risk Arbitrage Trades, Totaling Over C$11
-
Spotline to Showcase Innovative Solutions at DIA 2024 in San Diego
-
GD's Dongguan unleashes trend of Chinese art toys culture in San Francisco
-
"Inspiration as Response: Eugen Popa and Contemporary Chinese Painting Documentation Exhibition" Opens at the China Cultural Center in Bucharest, Romania
-
Brennan Acquires Two Distribution Buildings in Denver
-
Illumina appoints Everett Cunningham Chief Commercial Officer
-
Delicious Deal Alert: Domino's® Pizza is 50% Off This Week!
-
Alliance School's Rank in U.S. News & World Report's 2024 Best High Schools
-
RedHill Announces a New Patent Covering Opaganib in Combination with Immune Checkpoint Inhibitors, Valid Through 2040
-
Marriott International Announces Three Conversions to Bring Iconic Luxury Properties in the United States into the Marriott Bonvoy Portfolio Later This Summer
-
Coalesce Capital Announces Key Hires as Firm Continues to Expand Leadership Team
-
Dominion Energy Announces Closing of Sale of Western Natural Gas Distribution Assets Questar Gas, Wexpro
-
PEAK ROCK CAPITAL AFFILIATE COMPLETES PREVIOUSLY ANNOUNCED ACQUISITION OF HUFRIEDYGROUP
-
Recurrent Energy Announces Initial Closing of Investment from BlackRock
-
Labcorp Announces New Strategic Service Offerings within Precision Oncology Portfolio
-
Grey Wolf Therapeutics Presents First Clinical Data for GRWD5769, a First-in-Class ERAP1 Inhibitor, at the 2024 American Society for Clinical Oncology (ASCO) Annual Meeting
-
Pulsenmore Appoints Len Farris as Chief Commercial Officer to Lead Global Expansion of Breakthrough Home Ultrasound Technology
-
StateServ Rebrands to Dragonfly Health
-
EagleRider Motorcycle Rental and Tours Announces New CEO Sebastian Schoepe
-
Enbridge Completes Acquisition of Questar Gas Company
-
Graphite One Announces Repricing of Stock Options
-
Dunes Point Capital, LP Announces Roofing Services Solutions' Acquisition of West Orange Roofing, LLC
-
Gryphon Investors-Backed Thermal Technology Distribution Solutions Acquires Southwest Heater and Controls
